tiprankstipranks
Trending News
More News >
Cara Therapeutics (CARA)
NASDAQ:CARA
US Market

Cara Therapeutics (CARA) Income Statement

Compare
2,286 Followers

Cara Therapeutics Income Statement

Last quarter (Q4 2024), Cara Therapeutics's total revenue was $1.46M, a decrease of -51.56% from the same quarter last year. In Q4, Cara Therapeutics's net income was $-7.68M. See Cara Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 7.14M$ 20.97M$ 41.87M$ 23.03M$ 135.08M
Gross Profit
$ 7.14M$ 14.79M$ 34.60M$ 21.47M$ 28.01M
Operating Expenses
$ 65.52M$ 136.29M$ 122.14M$ 112.11M$ 129.70M
Depreciation and Amortization
$ 192.00K$ 259.00K$ 1.67M$ 1.55M$ 1.01M
EBITDA
$ -62.60M$ -117.65M$ -83.80M$ -88.19M$ 5.59M
Operating Income
$ -58.38M$ -121.50M$ -87.53M$ -89.08M$ 5.38M
Other Income/Expenses
$ -12.88M$ 2.98M$ 2.06M$ 642.00K$ 2.33M
Pretax Income
$ -71.27M$ -118.51M$ -85.47M$ -88.44M$ 7.72M
Net Income
$ -70.87M$ -118.51M$ -83.41M$ -88.19M$ 8.41M
Per Share Metrics
Basic EPS
$ -1.55$ -2.19$ -1.55$ -1.74$ 0.18
Diluted EPS
$ -1.55$ -2.19$ -1.55$ -1.74$ 0.18
Weighted Average Shares Outstanding
45.63M 54.15M 53.65M 50.72M 47.41M
Weighted Average Shares Outstanding (Diluted)
45.63M 54.15M 53.65M 50.72M 47.92M
Currency in USD

Cara Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis